Navigation Links
NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results
Date:10/30/2007

se actual results to differ materially from the statements made, including the risks associated with general economic conditions, competitive conditions in the radiology industry, and regulatory risks. Other factors that could cause operating and financial results to differ are described in the company's prospectus and periodic reports filed with the Securities and Exchange Commission (SEC). Other risks may be detailed from time to time in reports to be filed with the SEC. NightHawk does not undertake any obligation to publicly update its forward- looking statements based on events or circumstances after the date hereof.

Presentation of Non-GAAP Financial Information

The presentation of adjusted net income and adjusted earnings per diluted share are not measures of financial performance under GAAP and should not be considered a substitute for or superior to GAAP. Management believes these non-GAAP financial measures provide useful information to both management and investors by excluding certain expenses that may not be indicative of our core results and providing for consistency in financial reporting. Specifically, the company's non-GAAP adjusted net income measure, and related adjusted earnings per diluted share, described in this release exclude (i) for 2006 only, the non-cash charges related to the conversion feature and accretion of our preferred stock, which charges ceased upon the closing of our initial public offering when our shares of preferred stock converted into shares of common stock, (ii) the non-cash charges related to our stock-based compensation, (iii) the non-cash expense associated with the amortization of intangibles and (iv) the non-cash expense associated with changes to our IBNR reserve (incurred but not reported medical liability reserves). We exclude the non-cash charges related to our stock-based compensation due to the varying valuation methodologies, subjective assumptions and the variety of types of awards that companies ca
'/>"/>

SOURCE NightHawk Radiology Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Radiology advance points way to non-invasive brain cancer treatment
2. International Teleradiology: The Future Of Radiologic Diagnosis
3. Hospital Selected to ‘25 Most Influential’ List in Radiology in 206
4. President’s Address on the ‘Tele-Radiology’ Set Up of Krst
5. Kalam to Commission Indias First Tele-Radiology Network
6. Kalam Urges for Using Tele-radiology to Help Rural Poor
7. Radiology Workforce Shortage
8. Sweet corn releases antioxidants on cooking
9. An International Growth Standard For Childs Releases By WHO
10. The National Governors Association Releases Guidelines For Outbreak Of Bird Flu
11. Eli Lilly Releases Digital Insulin Pen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...ire-FirstCall/ -- Allscripts-Misys Healthcare,Sol...ions, Inc. (Allscripts or,the Company), today ann...,months ended November 30, 2008. , (Logo: ...CRIPTSLOGO-b ) , The Company,s results for ...include results from legacy Allscripts for the per...
(Date:1/8/2009)...re-USNewswire/ -- The Pew Charitable Trusts announ...or, chemical and food safety programs, in its Heal... was formerly deputy staff director and general co...ublic Works, brings nearly 25 years of experience ...ew. , , "We are excited to be joined by such a...
(Date:1/8/2009)...ipal. Christine Siu and Jason Brown, Ph.D. Promot...ISCO and STAMFORD, Conn., Jan. 8 T...ure capital firm that invests in life science and ...promotion of three members of its investment team....stine Siu and Jason Brown have been promoted to Vi...
(Date:1/8/2009)...wire-USNewswire/ -- A proposal by the State of Ind...ldren,s Home has prompted the 125,000-member Ameri...ual Mid-Winter conference January 10-12, 2009, in ...ly unanimous opposition to the proposal. , , Th...0 in direct and in-kind support to the home, is am...
Breaking Medicine News(10 mins):Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Thomas, McNerney & Partners Promotes Three Members of Its Investment Team 2
...dia received the Prince Mahidol Award 2006 from Th...tribution// to medical and public health services....evements in the discovery, introduction and widesp...on solution (ORS) or oral re-hydration therapy (OR...
... middle school girls in Maryland to be vaccinated ...s being shelved by its lead sponsor//. Sen. Delo...that she plans today to withdraw legislation that ...vaccinated against human papillomavirus, or HPV, a...
...ng device for patients is changing the way doctors...ibrillators//. Rush University Medical Center is ...tient Management system to determine if the wirele...ospitalizations for heart failure. A mini-antenna...
...Interview Survey (NHIS) suggest that at least 81 m...in during the winter months// due to blasts of col...d homes and offices. “Winter is no friend to the ...cca A. Kazin, M.D., assistant professor of dermato...
Other Medicine News:Health News:US, Indian Doctors Bag Thai Medical Awards 2Health News:Sponsor to Pull Measure Mandating HPV Vaccine 2Health News:Remote Device to Monitor Patients Daily at Their Homes 2
(Date:1/8/2009)...s treated at the initial dose in an ongoing Phase ...d decline after three days , , Conference Call ...ewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc....e first cohort of an ongoing Phase Ib clinical tri...cleoside polymerase inhibitor. ANA598 was very we...
(Date:1/7/2009)...CK, Md., Jan. 7 ImQuest Life Scien...n IND application to the Food and Drug Administrat...ad pyrimidinedione HIV inhibitor IQP-0410. ImQuest...he first quarter of 2009. IQP-0410 is a novel smal...s a nonnucleoside reverse transcriptase inhibitor ...
(Date:1/6/2009)... Expands on Successful Results from prior U.S., U....wswire/ -- Vital Therapies, Inc. (VTI), a developm...nnounced patient enrollment has begun for a random...rial that will study the Extracorporeal Liver Assi...Acute Liver Failure (ALF) under three protocols. T...
(Date:1/6/2009)...LE, Md., Jan. 6 Sequell...y focused on diseases of epidemic potential, annou... the treatment of tuberculosis (TB), was the first...linical program contract to Dynport Vaccine Compan...warded by the National Institute of Allergy and In...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Polyphenon Pharma Receives Orphan Drug Designation for Its Botanical Drug Polyphenon E for the Treatment of CLL 2711 1Polyphenon Pharma Receives Orphan Drug Designation for Its Botanical Drug Polyphenon E for the Treatment of CLL 2711 2Newly discovered monkey is threatened with extinction 4224 1Bone Density Predicts Chances of Breast Cancer 24436 1Bone Density Predicts Chances of Breast Cancer 24436 2Florida Dentist Launches Revolutionary Solution to National Dental Specialist Patient Care Dilemma 24432 1Florida Dentist Launches Revolutionary Solution to National Dental Specialist Patient Care Dilemma 24432 2Florida Dentist Launches Revolutionary Solution to National Dental Specialist Patient Care Dilemma 24432 3
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: